Cargando…
A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis
BACKGROUND: This cross-sectional study aims to investigate the association between subclinical atherosclerosis and metabolic dysfunction-associated fatty liver disease (MAFLD) or non-alcoholic fatty liver disease (NAFLD), and a synergistic effect of diabetes mellitus (DM) and MAFLD on subclinical at...
Autores principales: | Bessho, Rieko, Kashiwagi, Kazuhiro, Ikura, Akihiko, Yamataka, Karin, Inaishi, Jun, Takaishi, Hiromasa, Kanai, Takanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154100/ https://www.ncbi.nlm.nih.gov/pubmed/35639744 http://dx.doi.org/10.1371/journal.pone.0269265 |
Ejemplares similares
-
Clinical efficacy of immune checkpoint inhibitors in the treatment of unresectable advanced or recurrent gastric cancer: an evidence-based review of therapies
por: Togasaki, Kazuhiro, et al.
Publicado: (2018) -
The impact of visceral adipose tissue as best predictor for difficult colonoscopy and the clinical utility of a long small-caliber scope as rescue
por: Kashiwagi, Kazuhiro, et al.
Publicado: (2017) -
Subclinical thyroid dysfunction and risk of carotid atherosclerosis
por: Kim, Hosu, et al.
Publicado: (2017) -
Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China
por: Lei, Fang, et al.
Publicado: (2023) -
Clinical significance of subclinical atherosclerosis in retinal vein occlusion
por: Lyu, Minhyung, et al.
Publicado: (2021)